RecruitingNCT06630936

Study of Atrial Fibrillation Combined with Atrial Functional Mitral Regurgitation

Prospective Multi-Center Cohort Study of Atrial Fibrillation Combined with Atrial Functional Mitral Regurgitation


Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

500 participants

Start Date

Sep 27, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

To evaluate the improvement of mitral regurgitation after catheter ablation of atrial fibrillation or regular drug therapy in atrial fibrillation patients combined with atrial functional mitral regurgitation.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is examining the link between atrial fibrillation (an irregular heartbeat) and a type of mitral valve problem called atrial functional mitral regurgitation, where the valve leaks because the heart chamber has enlarged. Researchers want to better understand how to treat both conditions together. **You may be eligible if...** - You are between 18 and 80 years old - You have been diagnosed with symptomatic paroxysmal atrial fibrillation (episodes of irregular heartbeat, with less than 5 years of history) - You have moderate to severe mitral valve leakage with a normally functioning left ventricle **You may NOT be eligible if...** - Your atrial fibrillation is caused by thyroid problems or other reversible causes - You have active heart valve infection or rheumatic heart disease - You have moderate to severe narrowing of the mitral valve - You have a clot in your heart or heart chamber - You have a pacemaker, defibrillator, or CRT device already implanted - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Second Affiliated Hospital of Zhejiang University, School of Medicine

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06630936


Related Trials